India and the Netherlands have expanded bilateral cooperation in the healthcare, pharmaceutical, biotechnology, and medical technology sectors as part of the broader “Roadmap of India-Netherlands Strategic Partnership,” aimed at accelerating innovation, healthcare infrastructure development, research collaboration, and sustainable medical manufacturing.

The latest development follows high-level bilateral discussions between officials, healthcare industry representatives, and trade bodies focused on strengthening cooperation in pharmaceutical manufacturing, API supply chains, medical technology, digital health innovation, biotechnology research, hospital infrastructure, and sustainable healthcare systems.

India currently ranks among the world’s largest pharmaceutical producers, supplying nearly 20% of global generic medicines and over 60% of global vaccine demand, while the Netherlands remains one of Europe’s leading gateways for healthcare trade, medical technology, and life sciences investments.

Bilateral trade between India and the Netherlands has crossed approximately €27 billion (INR 2700 Crores) in recent years, making the Netherlands one of India’s largest European trading partners and a major foreign investor across healthcare, technology, logistics, and innovation driven sectors.

Healthcare and life sciences cooperation has emerged as a key pillar of the India Netherlands strategic roadmap, particularly after the global focus on resilient healthcare systems, diversified medical supply chains, and digital healthcare transformation following the COVID-19 pandemic.

Industry experts believe the collaboration could significantly strengthen India’s rapidly growing MedTech market, which is projected to reach nearly USD 50 billion by 2030, driven by increasing healthcare demand, hospital expansion, domestic manufacturing initiatives, and adoption of digital health technologies.

Officials from both countries stated that the expanded partnership will encourage startup collaborations, research exchange programs, innovation led manufacturing, and sustainable healthcare technologies aimed at improving patient outcomes, healthcare accessibility, and long

term public health resilience.

The latest engagement further reinforces India’s position as a global healthcare and pharmaceutical hub while deepening strategic healthcare and economic ties with European partners under long-term bilateral cooperation frameworks.